LitCovid-sample-Enju  

PMC:7205724 / 21851-22331 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T42975 0-5 CD denotes 6.2.1
T96891 7-17 NN denotes Hypothesis
T41163 17-18 -COLON- denotes :
T35174 19-20 DT denotes A
T74401 21-24 NN denotes mAb
T75556 25-32 IN denotes against
T83617 33-36 NN denotes IL6
T67953 37-40 MD denotes can
T68840 41-50 VB denotes attenuate
T2426 51-56 NN denotes hyper
T92661 57-69 NN denotes inflammation
T86439 70-81 NNP denotes Tocilizumab
T21494 81-82 -COMMA- denotes ,
T50157 83-87 RB denotes also
T26283 88-93 VBN denotes known
T43571 94-96 IN denotes as
T44785 97-106 NN denotes atlizumab
T96810 106-107 -COMMA- denotes ,
T58761 108-110 VBZ denotes is
T56416 111-112 DT denotes a
T79548 113-122 JJ denotes humanized
T29074 123-133 JJ denotes anti-human
T88685 134-137 NN denotes IL6
T26777 138-146 NN denotes receptor
T24185 147-155 NN denotes antibody
T17221 156-164 VBN denotes approved
T32471 165-167 IN denotes by
T53882 168-171 NNP denotes FDA
T24580 172-175 IN denotes for
T33924 176-183 JJ denotes several
T90119 184-196 JJ denotes inflammatory
T59846 197-200 CC denotes and
T31666 201-211 JJ denotes autoimmune
T46803 212-220 NNS denotes diseases
T80969 221-227 JJ denotes severe
T13017 227-228 -COMMA- denotes ,
T79015 229-233 JJ denotes such
T43255 234-236 IN denotes as
T47553 237-245 NN denotes cytokine
T34694 246-253 NN denotes release
T36705 254-262 NN denotes syndrome
T68837 262-263 -COMMA- denotes ,
T30269 264-274 JJ denotes rheumatoid
T54700 275-284 NN denotes arthritis
T81658 284-285 -COMMA- denotes ,
T84650 286-291 JJ denotes giant
T11095 292-296 NN denotes cell
T15987 297-306 NN denotes arteritis
T88887 306-307 -COMMA- denotes ,
T31599 308-321 JJ denotes polyarticular
T93322 322-330 JJ denotes juvenile
T49595 331-341 JJ denotes idiopathic
T62141 342-351 NN denotes arthritis
T76737 351-352 -COMMA- denotes ,
T30470 353-356 CC denotes and
T13999 357-367 JJ denotes systematic
T88238 368-376 JJ denotes juvenile
T89892 377-387 JJ denotes idiopathic
T97598 388-397 NN denotes arthritis
T25454 399-401 PRP denotes It
T28665 402-404 VBZ denotes is
T15312 405-409 JJ denotes safe
T18121 410-413 CC denotes and
T2467 414-423 JJ denotes effective
T39207 424-427 IN denotes for
T89869 428-432 DT denotes both
T32842 433-439 NNS denotes adults
T38357 440-443 CC denotes and
T13891 444-452 NNS denotes children
T61388 453-456 CD denotes two
T66576 457-462 NNS denotes years
T46590 463-465 IN denotes of
T15404 466-469 NN denotes age
T19164 470-473 CC denotes and
T99851 474-479 JJR denotes older
R12170 T62141 T88887 arg2Of arthritis,","
R12475 T15987 T11095 arg1Of arteritis,cell
R13146 T26283 T50157 arg1Of known,also
R13465 T46803 T33924 arg1Of diseases,several
R14765 T96891 T68840 arg1Of Hypothesis,attenuate
R18021 T53882 T17221 arg1Of FDA,approved
R19260 T54700 T68837 arg2Of arthritis,","
R19276 T24185 T56416 arg1Of antibody,a
R19638 T30470 T76737 arg1Of and,","
R20734 T80969 T24580 arg2Of severe,for
R20864 T81658 T88887 arg1Of ",",","
R21524 T24185 T26777 arg1Of antibody,receptor
R21959 T36705 T34694 arg1Of syndrome,release
R2263 T24185 T88685 arg1Of antibody,IL6
R23852 T97598 T89892 arg1Of arthritis,idiopathic
R24087 T24185 T79548 arg1Of antibody,humanized
R24341 T43255 T79015 arg1Of as,such
R24950 T38357 T99851 arg1Of and,older
R2665 T97598 T13999 arg1Of arthritis,systematic
R2759 T62141 T31599 arg1Of arthritis,polyarticular
R27887 T17221 T24580 arg1Of approved,for
R32577 T74401 T41163 arg2Of mAb,:
R33248 T30470 T43255 arg2Of and,as
R33385 T25454 T15312 arg1Of It,safe
R33791 T99851 T19164 arg2Of older,and
R34196 T13891 T38357 arg2Of children,and
R37501 T66576 T61388 arg1Of years,two
R41949 T36705 T68837 arg1Of syndrome,","
R42046 T15987 T84650 arg1Of arteritis,giant
R42821 T97598 T88238 arg1Of arthritis,juvenile
R4444 T31666 T59846 arg2Of autoimmune,and
R45357 T36705 T47553 arg1Of syndrome,cytokine
R47508 T97598 T30470 arg2Of arthritis,and
R48338 T24185 T58761 arg2Of antibody,is
R50655 T88887 T30470 arg1Of ",",and
R56313 T62141 T93322 arg1Of arthritis,juvenile
R57671 T62141 T49595 arg1Of arthritis,idiopathic
R58214 T53882 T32471 arg2Of FDA,by
R58839 T74401 T75556 arg1Of mAb,against
R59437 T54700 T30269 arg1Of arthritis,rheumatoid
R60939 T90119 T59846 arg1Of inflammatory,and
R63345 T18121 T28665 arg2Of and,is
R6462 T44785 T43571 arg2Of atlizumab,as
R64820 T96891 T41163 arg1Of Hypothesis,:
R65301 T58761 T96810 arg1Of is,","
R65763 T25454 T28665 arg1Of It,is
R65895 T24185 T29074 arg1Of antibody,anti-human
R71645 T15312 T18121 arg1Of safe,and
R72696 T83617 T75556 arg2Of IL6,against
R74784 T68840 T67953 arg2Of attenuate,can
R76811 T26283 T43571 arg1Of known,as
R77190 T66576 T19164 arg1Of years,and
R77360 T38357 T89869 arg1Of and,both
R77534 T24185 T17221 arg2Of antibody,approved
R78333 T32842 T38357 arg1Of adults,and
R79527 T74401 T35174 arg1Of mAb,A
R79824 T2467 T18121 arg2Of effective,and
R79844 T68837 T81658 arg1Of ",",","
R80686 T66576 T46590 arg1Of years,of
R81304 T38357 T39207 arg2Of and,for
R82868 T86439 T26283 arg2Of Tocilizumab,known
R83125 T86439 T21494 arg1Of Tocilizumab,","
R84073 T96891 T67953 arg1Of Hypothesis,can
R85448 T38357 T66576 arg1Of and,years
R86212 T46803 T90119 arg1Of diseases,inflammatory
R86934 T18121 T39207 arg1Of and,for
R87485 T46803 T31666 arg1Of diseases,autoimmune
R87665 T25454 T2467 arg1Of It,effective
R90538 T46803 T80969 arg1Of diseases,severe
R91756 T86439 T58761 arg1Of Tocilizumab,is
R92175 T15404 T46590 arg2Of age,of
R92270 T96891 T42975 arg1Of Hypothesis,6.2.1
R92610 T24185 T43255 arg1Of antibody,as
R94556 T92661 T68840 arg2Of inflammation,attenuate
R96846 T15987 T81658 arg2Of arteritis,","
R97819 T17221 T13017 arg1Of approved,","
R98822 T92661 T2426 arg1Of inflammation,hyper